Morbidity of second-look surgery in pediatric central nervous system tumors

被引:21
|
作者
Khan, RB [1 ]
Sanford, RA [1 ]
Kun, LE [1 ]
Thompson, SJ [1 ]
机构
[1] St Jude Childrens Res Hosp, Dept Radiat Oncol, Div Neurol, Memphis, TN 38105 USA
关键词
second-look surgery; brain tumor; morbidity;
D O I
10.1159/000050426
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The extent of brain tumor resection affects survival. Second-look surgery (resection of residual tumor before radiographic progression) may improve survival by reducing the tumor burden, but the morbidity of the procedure is not known. On chart review of 280 patients with two or more brain tumor operations treated between January 1985 and June 1998, we identified 47 patients with second-look surgery. Lansky and Eastern Cooperative Oncology Group (ECOG) performance scores, as well as perioperative complications were recorded. There were 21 gliomas (6 malignant), 12 medulloblastomas, 3 craniopharyngiomas, 3 ependymomas and 8 miscellaneous tumors. Median time to second surgery was 50 days. Perioperative complications occurred in 45% of patients. There was no significant change in the mean Lansky and ECOG scores 4 and 24 weeks after surgery. Gross total resection (GTR) was achieved in 62% of patients and near total resection (NTR) in 23%, and 15% of patients had subtotal resection. GTR or NTR was achieved in 66% of medulloblastomas and 100% of gliomas. We conclude that second-look surgery by experienced pediatric neurosurgeons has an acceptable morbidity and should be considered in patients with residual tumors. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:225 / 229
页数:5
相关论文
共 50 条
  • [41] Relapse patterns in pediatric embryonal central nervous system tumors
    Sébastien Perreault
    Robert M. Lober
    Anne-Sophie Carret
    Guohua Zhang
    Linda Hershon
    Jean-Claude Décarie
    Kristen Yeom
    Hannes Vogel
    Paul G. Fisher
    Sonia Partap
    Journal of Neuro-Oncology, 2013, 115 : 209 - 215
  • [42] Indications and procedures for second-look surgery in acute mesenteric ischemia
    Meng, Xianzhi
    Liu, Lianxin
    Jiang, Hongchi
    SURGERY TODAY, 2010, 40 (08) : 700 - 705
  • [43] Germline genetic landscape of pediatric central nervous system tumors
    Muskens, Ivo S.
    Zhang, Chenan
    de Smith, Adam J.
    Biegel, Jaclyn A.
    Walsh, Kyle M.
    Wiemels, Joseph L.
    NEURO-ONCOLOGY, 2019, 21 (11) : 1376 - 1388
  • [44] Advances in the biology and treatment of pediatric central nervous system tumors
    Vitanza, Nicholas A.
    Cho, Yoon-Jae
    CURRENT OPINION IN PEDIATRICS, 2016, 28 (01) : 34 - 39
  • [45] A GLOBAL PERSPECTIVE ON THE BURDEN OF PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS
    Moreira, Daniel
    Qaddoumi, Ibrahim
    Bhakta, Nickhill
    Gajjar, Amar
    Rodriguez-Galindo, Carlos
    NEURO-ONCOLOGY, 2020, 22 : 320 - 320
  • [46] Pediatric central nervous system germ cell tumors:: A review
    Echevarria, Maria E.
    Fangusaro, Jason
    Goldman, Stewart
    ONCOLOGIST, 2008, 13 (06): : 690 - 699
  • [47] Systemic inflammatory response in pediatric central nervous system tumors
    Ravi Sharma
    Varidh Katiyar
    Prateek Sharma
    Hitesh Gurjar
    Acta Neurochirurgica, 2018, 160 : 1215 - 1216
  • [48] Relapse patterns in pediatric embryonal central nervous system tumors
    Perreault, Sebastien
    Lober, Robert M.
    Carret, Anne-Sophie
    Zhang, Guohua
    Hershon, Linda
    Decarie, Jean-Claude
    Yeom, Kristen
    Vogel, Hannes
    Fisher, Paul G.
    Partap, Sonia
    JOURNAL OF NEURO-ONCOLOGY, 2013, 115 (02) : 209 - 215
  • [49] Late Effects of Treatment of Pediatric Central Nervous System Tumors
    Roddy, Erika
    Mueller, Sabine
    JOURNAL OF CHILD NEUROLOGY, 2016, 31 (02) : 237 - 254
  • [50] Systemic inflammatory response in pediatric central nervous system tumors
    Sharma, Ravi
    Katiyar, Varidh
    Sharma, Prateek
    Gurjar, Hitesh
    ACTA NEUROCHIRURGICA, 2018, 160 (06) : 1215 - 1216